在动脉样硬化心血管疾病中血液代谢重新连接
Laurent Yvan-Charvet1,2,3, Thibault Barouillet4,5,6, Coraline Borowczyk7,8,9
1Institut National de la Santé et de la Recherche Médicale (Inserm) U1065, Nice, France. yvancharvet@unice.fr.
Nature reviews. Cardiology
|January 1, 2025
概括
本综述探讨了心血管风险因素如何影响"血液代谢"和"血液代谢". 了解这些代谢过程可能会导致治疗动脉样硬化并发症的新疗法.
科学领域:
- 心血管科学 心血管科学
- 免疫学 免疫学 免疫学
- 代谢研究研究 代谢研究
背景情况:
- 动脉样硬化心血管疾病是全球主要的死亡原因.
- 动脉样硬化的临床并发症与造血和免疫系统功能密切相关.
- 代谢和炎症之间的相互作用对于诸如动脉样硬化等非传染性疾病至关重要.
研究的目的:
- 研究心血管风险因素和代谢修饰剂如何影响血液代谢和血液代谢.
- 阐明在动脉样硬化中这些代谢过程背后的分子和细胞机制.
- 探索动脉样硬化并发症的潜在治疗点.
主要方法:
- 审查有关新陈代谢,炎症和动脉样硬化的现有文献.
- 分析分子和细胞途径,涉及到血液形成和血细胞分裂.
- 探讨心血管风险因素在代谢重编程中的作用.
主要成果:
- 心血管疾病的危险因素可以改变血液代谢 (造血干细胞倾斜) 和血代谢 (血细胞重编程).
- 这些代谢变化可能会影响巨细胞供应链,影响动脉样硬化进展.
- 了解这些机制,可以了解疾病的发病性.
结论:
- 向血液代谢是一种潜在的动脉样硬化治疗策略.
- 代谢疗法和生活方式改变的结合方法可以降低动脉样硬化风险.
- 需要进一步研究血液构成和血细胞形成的代谢要求.
相关概念视频
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...


